Clonidine interactions
Pro Research Analysisby 
Searched over 200M research papers for "clonidine interactions"
Clonidine Interactions: A Comprehensive Overview
Clonidine and Tricyclic Antidepressants: Blood Pressure Control
The interaction between clonidine, an antihypertensive agent, and tricyclic antidepressants (TCAs) such as desipramine has been shown to significantly impact blood pressure control. In a study involving hypertensive patients, the introduction of desipramine led to a notable loss of blood pressure control, with an average increase of 22/15 mm Hg in the lying position and 12/11 mm Hg standing . This suggests that TCAs can counteract the antihypertensive effects of clonidine, potentially due to their influence on noradrenaline uptake or competition at central alpha-receptors.
Clonidine and Tetracyclic Antidepressants: No Significant Interaction
In contrast to TCAs, the tetracyclic antidepressant maprotiline does not appear to interfere with clonidine's antihypertensive action. A study involving healthy subjects found that concurrent administration of maprotiline did not alter the blood pressure-lowering effects of clonidine . This indicates that maprotiline may be a safer alternative for treating depression in hypertensive patients on clonidine therapy.
Clonidine and Neostigmine: Enhanced Analgesia
The combination of clonidine and intrathecal neostigmine has been investigated for its analgesic effects. The results showed that this combination leads to additive enhancement of analgesia without increasing the side effects of either drug. Additionally, neostigmine was found to reduce clonidine-induced hypotension, making this combination potentially useful for clinical pain management .
Clonidine and Histamine H2 Receptor Antagonists: Reversal of Hypotension
Clonidine-induced hypotension can be antagonized by histamine H2 receptor antagonists such as metiamide and cimetidine. In animal studies, intracerebroventricular administration of these antagonists significantly reversed the hypotensive and bradycardic effects of clonidine . This suggests a central interaction between clonidine and histamine H2 receptors, which could be relevant for managing clonidine-induced hypotension in clinical settings.
Clonidine and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Synergistic Antinociception
The interaction between clonidine and NSAIDs has been shown to produce synergistic antinociceptive effects when administered systemically. This synergy was observed in acute visceral pain models, indicating that combining clonidine with NSAIDs could enhance pain relief more effectively than either drug alone .
Clonidine and Opiates: Additive and Synergistic Effects
Clonidine also interacts positively with opiates to produce antinociception. The combination of clonidine with opiates such as morphine, fentanyl, and meperidine has been shown to result in additive or synergistic effects, depending on the route of administration and the type of nociceptive test used. This interaction suggests that clonidine can enhance the pain-relieving effects of opiates, potentially allowing for lower doses of opiates to be used .
Clonidine and Beta-Blockers: Additive Antihypertensive Effects
The combination of clonidine with the beta-blocker acebutolol has been found to produce additive antihypertensive effects. This combination not only significantly reduced blood pressure but also influenced water and electrolyte balance, indicating a parallel inhibition of the renin and sympathetic systems . This suggests that combining clonidine with beta-blockers could be an effective strategy for managing hypertension.
Clonidine and ADHD Medications: Safety and Tolerability
Clonidine is also used in the treatment of attention-deficit/hyperactivity disorder (ADHD). When used alone or in combination with methylphenidate, clonidine has been found to be safe and well-tolerated in children. However, there is an increased incidence of bradycardia and initial drowsiness, which generally resolves over time . This highlights the importance of monitoring cardiovascular outcomes when prescribing clonidine for ADHD.
Conclusion
Clonidine interacts with a variety of drugs, leading to significant clinical implications. While it can enhance analgesic effects when combined with neostigmine, NSAIDs, and opiates, it can also lead to loss of blood pressure control when used with TCAs. However, tetracyclic antidepressants like maprotiline do not exhibit this interaction. Additionally, clonidine's hypotensive effects can be reversed by histamine H2 receptor antagonists, and its combination with beta-blockers shows additive antihypertensive effects. In ADHD treatment, clonidine is generally safe but requires monitoring for bradycardia. Understanding these interactions is crucial for optimizing clonidine's therapeutic use and minimizing adverse effects.
Sources and full results
Most relevant research papers on this topic